编辑丨于靖
9月13日,Akero Therapeutics宣布旗下药物Efruxifermin(EFX,曾用名AKR-001)在IIb期HARMONY研究中,可改善肝硬化前期非酒精性脂肪性肝炎(NASH)患者的肝纤维化并防止疾病恶化,Efruxifermin 28mg和50mg剂量组均达到了改善肝脏纤维化的主要终点以及多个次要终点...查看全文
chuminhua2021-08-26 14:55
8月25日,Lipocine公司宣布,其在研疗法LPCN 1144,在治疗非酒精性脂肪性肝炎(NASH)男性患者的2期概念验证临床试验LiFT中获得积极结果。LPCN 1144是一种口服的睾酮前药。NASH是全球肝衰竭和肝移植的主要原因,是非酒精性脂肪性肝病(NAFLD)的一种更晚期状态,可进展为肝硬化,最终发展为肝癌。...查看全文
SnowBall2020Q42021-02-05 22:17
$Lipocine(LPCN)$ 号称口服睾丸酮对于老年男性新冠患者有帮助,但是炒作第一波已经过了。口服治疗方案具体咋样还没有仔细研究。查看全文
$Lipocine Inc.(LPCN)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-12 AccNo: 0001144204-18-013981 Size: 5 MB 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-02-16 AccNo: 0001144204-18-009421 Size: 34 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0001104659-18-009151 Size: 309 KB 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-02-13 AccNo: 0001144204-18-007494 Size: 14 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-02-08 AccNo: 0001144204-18-006439 Size: 35 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-06 AccNo: 0000914208-18-000028 Size: 18 KB 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-01-10 AccNo: 0001144204-18-001723 Size: 37 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-01-09 AccNo: 0001144204-18-001410 Size: 317 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registra...
$Lipocine Inc.(LPCN)$ 8-K - Current report Filed: 2018-01-08 AccNo: 0001144204-18-001218 Size: 26 KBItem 8.01: Other Events 网页链接
$Lipocine Inc.(LPCN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-03 AccNo: 0000906304-18-000001 Size: 7 KB 网页链接